Skip to content

EPRX - EUPRAXIA PHARMACEUTICALS INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchE

Eupraxia Pharmaceuticals Inc. Common Stock

EPRX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

E

EPRXEupraxia Pharmaceuticals Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $9.32
52-wk low: $5.04
Prev close: $8.32
Mkt cap: $462.0M
Beta: 1.50
P/B: 4.2x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$24.5M

BA
Balyasny
Dmitry Balyasny · Q2 2026 13F
$8.9M
position
P7
Point72
Steven Cohen · Q2 2026 13F

Earnings

Reported Aug 11, 2026

Earnings came in 8.0% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $462M

Valuation

P/B4.17

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: EPRX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $462.01M
Beta: 1.50

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-66.7%

$4.8M

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$3.3M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for EPRX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.23+8.0%

-$0.25 expected

Next report

What the street expects next

EPS expected

-$0.23

-$0.29 to -$0.17

Revenue expected

$0.00

8 analysts

Estimate drift

+0.01

Change in 30 days

-66.7%

ROA-43.7%

Growth

Beta1.50